Table 6 Overall results (irrespective of site of primary tumor)

N+

RND

10% – 22%

MRND type I

4.8% – 26%

N1

RND

8% – 15%

MRND type I

0 – 16%

N2

RND

12% – 26%

MRND type I

15% – 25%

N3

RND

21%